Status:
UNKNOWN
Jikei Optimal Insulin Therapy in Type 2 Diabetes
Lead Sponsor:
Jikei University School of Medicine
Collaborating Sponsors:
Novo Nordisk A/S
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
The purpose of this study is to compare whether there is the difference in the effect of insulin therapy by the number of times of insulin injection.
Detailed Description
The current insulin therapy is divided into the conventional insulin therapy (1\~2 injections per day) and the intensive insulin therapy (3\~4 injections per day). The kinetics of exogenous insulin in...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Type 2 diabetes
- secondary failure of SU drug
- whose age is to 80 from 20 years old
Exclusion
- who has the complication
- who has a allergy of insulin
- who is pregnant
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
End Date :
August 1 2006
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00348231
Start Date
November 1 2004
End Date
August 1 2006
Last Update
September 1 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Jikei university school of medicine division of diabetes and endoclinology dept. of internal medicine
Tokyo, Tokyo, Japan, 1058461